Log In
Print
BCIQ
Print
Print this Print this
 

Xience Xpedition Everolimus Eluting Coronary Stent System

Also known as: Xience Xpedition

  Manage Alerts
Collapse Summary General Information
Company Abbott Laboratories
DescriptionEverolimus-eluting coronary stent system
Molecular Target Mammalian target of rapamycin (mTOR) (FRAP) (RAFT1)
Mechanism of Action 
Latest Stage of DevelopmentMarketed
IndicationCoronary artery disease (CAD)
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today